- Report
- September 2023
- 107 Pages
Asia Pacific
From €3050EUR$3,450USD£2,633GBP
- Report
- September 2023
- 112 Pages
Europe
From €3050EUR$3,450USD£2,633GBP
- Report
- September 2023
- 101 Pages
North America
From €2608EUR$2,950USD£2,252GBP
- Report
- September 2023
- 194 Pages
Global
From €4377EUR$4,950USD£3,778GBP
- Report
- November 2022
- 160 Pages
Global
€3006EUR$3,400USD£2,595GBP
- Report
- December 2018
- 14 Pages
Global
From €8841EUR$10,000USD£7,633GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- August 2023
- 108 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- October 2023
- 74 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- September 2023
- 74 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- October 2023
- 100 Pages
Africa
From €884EUR$1,000USD£763GBP
€1768EUR$2,000USD£1,527GBP
- Report
- October 2023
- 80 Pages
Russia
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
Ireland
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
China
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
Brazil
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- October 2023
- 80 Pages
Poland
From €663EUR$750USD£572GBP
€1326EUR$1,500USD£1,145GBP
- Report
- January 2025
- 132 Pages
Global
From €840EUR$950USD£725GBP
- Report
- November 2024
- 90 Pages
Australia
From €1644EUR$1,859USD£1,419GBP
- Book
- January 2015
- 464 Pages
- Book
- October 2012
- 1570 Pages

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more